Internal Medicine, Infectious Disease · Austin, TX
NPI
1407874027
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1301 W 38th St, Suite 403
Austin, TX, 78705
Phone (512) 459-9710
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
11,454 services
Medicare patients, 2024
165
Average age 72
Drug cost, 2024
$1.7M
1,446 prescriptions
Company payments, 2025
$917
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jack D Bissett was code 99213 (office e&m - established), 90 times for 65 patients. In total Jack D Bissett billed 11,454 services in 40 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 90 | 65 | $59.55 | $5,359 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 75 | 67 | $23.41 | $1,756 |
| 99223 Hospital E&M - Initial | Facility | 73 | 68 | $133.59 | $9,752 |
| 99231 Hospital E&M - Subsequent | Facility | 64 | 38 | $38.78 | $2,482 |
| 99232 Hospital E&M - Subsequent | Facility | 58 | 35 | $61.69 | $3,578 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 55 | 25 | $78.60 | $4,323 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 18 | $11.06 | $299 |
| 99212 Office E&M - Established | Office | 24 | 23 | $43.19 | $1,037 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 21 | 21 | $41.39 | $869 |
| 99222 Hospital E&M - Initial | Facility | 15 | 15 | $102.51 | $1,538 |
| 99233 Hospital E&M - Subsequent | Facility | 14 | 11 | $92.72 | $1,298 |
By year: 2022 $254K for 10,671 services; 2023 $212K for 54,142 services; 2024 $114K for 11,454 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jack D Bissett prescribed most often to Medicare patients was Cephalexin, with 89 prescriptions and refills. In total Jack D Bissett wrote 1,446 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 89 | 151 | 21 | $2,782 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 82 | 90 | Under 11 | $363K |
| Isentress Raltegravir Potassium | 81 | 89 | Under 11 | $172K |
| Amoxicillin Generic | 75 | 137 | 24 | $857 |
| Tivicay Dolutegravir Sodium | 73 | 73 | Under 11 | $183K |
| Descovy Emtricitabine/Tenofov Alafenam | 66 | 66 | Under 11 | $143K |
| Doxycycline Hyclate Generic | 52 | 60 | 12 | $1,369 |
| Abacavir Abacavir Sulfate | 50 | 58 | Under 11 | $11K |
| Dovato Dolutegravir Sodium/Lamivudine | 49 | 49 | Under 11 | $146K |
| Juluca Dolutegravir/Rilpivirine | 42 | 42 | Under 11 | $140K |
| Etravirine Generic | 41 | 49 | Under 11 | $45K |
| Cefazolin Sodium Generic | 40 | 40 | Under 11 | $1,737 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 40 | 50 | Under 11 | $175K |
| Zidovudine Generic | 36 | 44 | Under 11 | $1,432 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 79 | 11 | $593 |
Brand drugs: 529 claims; generic drugs: 917 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jack D Bissett $917 ($917 in general payments such as food, travel and fees) from 12 companies. The largest payer was Gilead Sciences, Inc. with $351.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 13 | $351 |
| Merck Sharp & Dohme LLC MRK | 5 | $156 |
| Abbvie Inc. ABBV | 3 | $77.41 |
| ViiV Healthcare Company GSK | 3 | $75.52 |
| Astellas Pharma US Inc 4503.T | 3 | $66.29 |
| Hospira, Inc. PFE | 2 | $43.62 |
| Paratek Pharmaceuticals, Inc. | 1 | $33.71 |
| Octapharma USA, Inc. | 2 | $32.32 |
| Cumberland Pharmaceuticals, Inc. CPIX | 2 | $30.27 |
| Insmed, Inc. INSM | 1 | $18.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.